Retension (RTSN) traded down -5.06 % during a 24 hours period ending at 08:05 AM Central Europe on Wednesday 28th. One Retension stock can currently be bought for about USD 13.52 on popular exchanges. Retension has a current market capitalization of USD 118.2 mn and approximately USD 1 mn worth of Retension was traded on exchanges in the last 24 hours. Simple moving average of last 200 days is at USD 13.65. The highest price of past 52 weeks was recorded at USD 18.64 on 10/19/2026. 52 weeks low was at USD 9.66 on 10/09/2026.
Here is how related stocks have performed in the past 24 hours:
Journey Medical (DERM) traded down -0.2 % and now trades at USD 4.96. Journey Medical has a market capitalisation of USD 140.6 mn.
Xflh Capital (XFLH) traded flat 0 % and now trades at USD 10.1. Current market capitalisation for Xflh Capital is USD 140.3 mn.
Bhav Acquisition (BHAV) traded down -0.2 % and now trades at USD 10.08. Current market capitalisation for Bhav Acquisition is USD 141.7 mn.
Eagle Nuclear Energy (NUCL) traded flat 0 % and now trades at USD 4.75. Eagle Nuclear Energy has a market capitalisation of USD 140.5 mn. Eagle Nuclear Energy Corp. reported progress on its Aurora Uranium Project, noting that a planned 27,000‑foot, 47‑hole drill program will begin once Oregon permits are secured. Technical consultants and government affairs advisers have been appointed to support the project, with the pre‑feasibility study targeted for completion in the second half of 2027. Eagle’s cash balance remained robust, with no debt, and the company was added to a global uranium index, qualifying it for inclusion in a uranium exchange‑traded fund. The company highlighted potential deferred equity payments linked to resource classification upgrades and the delivery of a positive pre‑feasibility study. Aurora, holding Eagle’s shares, continues to seek a higher valuation of its investment and maintains a steady cash position, supporting ongoing exploration activities in Western Australia.
Codexis (CDXS) traded down -1.54 % and now trades at USD 1.28. Current market capitalisation for Codexis is USD 141.8 mn.